VCANBIO Competitors and Similar CompaniesClear all

VCANBIO's competitors and similar companies include Lyra Therapeutics and Adaptive Phage Therapeutics.
VCANBIO
VCANBIO
VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products.
Lyra Therapeutics
Lyra Therapeutics
Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases.
Adaptive Phage Therapeutics
Adaptive Phage Therapeutics
Adaptive Phage Therapeutics (APT) is a clinical-stage company.
Founding Date
Founding Date
1993
Founding Date
2005
Founding Date
2016
Type
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Tianjin, CN HQ
Locations
Watertown, US HQ
Locations
Gaithersburg, US HQ
Gaithersburg, US
Employees
Employees
2,0149% decrease
Employees
34
Employees
244% decrease
Valuation ($)
Valuation ($)
1.4 b
Valuation ($)
17.4 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
¥1.4b (FY, 2025)
Revenue (est.)
$398k (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
¥103.5m (FY, 2025)
Net income
($28.9m) (FY, 2025)
Net income
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 59.5m
Total funding raised
$ 20.3m
For sources of this data, please see the company profile

View Company Profiles

Lyra Therapeutics
HQ
Watertown, US
Employees
34

Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases.

View company
Adaptive Phage Therapeutics
HQ
Gaithersburg, US
Employees
24↓ 4% decrease

Adaptive Phage Therapeutics (APT) is a clinical-stage company.

View company